Evidence Lacking for Cannabinoid Use in Children With Cancer
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Aug. 30, 2023 -- There is a lack of evidence regarding the dosing, safety, and efficacy of cannabinoids for children with cancer, according to a review published online Aug. 28 in Cancer.
Manik Chhabra, Pharm.D., from the University of Manitoba in Winnipeg, Canada, and colleagues conducted a systematic review to appraise the existing published literature for cannabis product use in children with cancer. A total of 19 unique studies with 1,927 participants with cancer were included: eight retrospective chart reviews, seven randomized controlled trials, two open-label studies, and two case reports.
The researchers found that the studies reported use of various cannabis products for symptom management. Eleven of the studies (58 percent) reported use of cannabinoids for the management of chemotherapy-induced nausea and vomiting. Somnolence, dizziness, dry mouth, and withdrawal due to adverse events were more commonly associated with use of cannabinoids in controlled studies. No serious cannabis-related adverse events were reported across any of the included studies.
"Data are lacking on cannabinoids' effects on pain, mood, sleep, and health-related quality of life," coauthor Lauren E. Kelly, Ph.D., also from the University of Manitoba, said in a statement. "Given that some children report benefits and some children experience adverse events, it is critical that more rigorous studies evaluating the effects of cannabinoids on children with cancer are conducted and shared with parents, patients, and the health care community."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Read this next
One in Six Primary Care Patients Report Cannabis Use
FRIDAY, June 7, 2024 -- One in six adult primary care patients report using cannabis, according to a study published online June 5 in JAMA Network Open. Lillian Gelberg...
32 Percent of U.S. Adults Know Someone Who Died of a Drug Overdose
MONDAY, June 3, 2024 -- Thirty-two percent of U.S. adults report knowing someone who died of a drug overdose, according to a study published online May 31 in JAMA Health...
Racial Disparity Seen in Naloxone Administration
FRIDAY, May 31, 2024 -- In Pennsylvania, from 2019 to 2021, Black people who died from overdose deaths had lower odds of naloxone administration compared with White and Hispanic...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.